Advancements in cancer diagnostics are revolutionizing early detection, improving accuracy, and enhancing patient outcomes. New technologies, including liquid biopsy and AI-powered imaging, are enabling faster and more precise diagnosis. These innovations are facilitating personalized treatment plans and earlier interventions, significantly impacting the effectiveness of cancer care. This session will focus on the latest diagnostic tools, their clinical applications, and their potential to transform oncology practices.

Tracks:

Track 1-1: Liquid Biopsy
Track 1-2: AI in Imaging & Biomarkers in Diagnosis
Track 1-3: Genomic Profiling
Track 1-4: Early Detection Techniques
Track 1-5: Next-Generation Sequencing (NGS)

Chemotherapy remains a cornerstone of cancer treatment, targeting rapidly dividing cancer cells to inhibit their growth. Over the years, advances in drug formulations and delivery methods have enhanced its effectiveness while reducing side effects. This session will explore the latest developments in chemotherapy, including combination therapies and novel drug targets, aimed at improving patient outcomes and minimizing toxicities.

Tracks:

Track 2-1: Advances in Drug Formulations
Track 2-2: Delivery Methods
Track 2-3: Combination Therapies
Track 2-4: Novel Drug Targets
Track 2-5: Managing Side Effects & Targeted Chemotherapy

Stem cells play a critical role in cancer research by offering insights into cancer development, progression, and recurrence. They hold promise in understanding tumor biology and developing more effective treatments. Recent studies have highlighted how cancer stem cells contribute to drug resistance and metastasis, making them a focal point in therapeutic strategies. This session will explore the latest findings in stem cell research and their potential applications in cancer treatment.

Tracks:

Track 3-1: Cancer Stem Cells
Track 3-2: Role in Tumor Biology
Track 3-3: Implications for Treatment
Track 3-4: Research Advances
Track 3-5: Challenges in Targeting CSCs

Plasma technology is emerging as an innovative approach in cancer treatment, utilizing ionized gases to target and destroy cancer cells. This non-invasive technique offers potential advantages in precision therapy, reducing damage to surrounding healthy tissues. Plasma-based treatments are showing promise in enhancing the effectiveness of traditional therapies and improving patient outcomes. This session will explore the science behind plasma technology and its evolving role in cancer care.

Tracks:

Track 4-1: Plasma-Based Cancer Therapy
Track 4-2: Mechanisms of Action
Track 4-3: Non-Invasive Treatment & Future Perspectives
Track 4-4: Combination with Traditional Therapies
Track 4-5: Current Research and Developments

Emerging therapies in oncology are transforming the landscape of cancer treatment by focusing on targeted approaches, immunotherapy, and novel drug discoveries. These advancements are offering new hope for patients with previously hard-to-treat cancers. Cutting-edge therapies are not only improving survival rates but also enhancing the quality of life for cancer patients. This session will explore the most promising therapies, including immune checkpoint inhibitors, gene therapy, and other novel treatment strategies.

Tracks:

Track 5-1: Immunotherapy
Track 5-2: Targeted Therapy
Track 5-3: Gene Therapy
Track 5-4: Combination Treatments
Track 5-5: Future Directions

Pediatric Oncology focuses on diagnosing and treating cancers in children, a field that requires specialized approaches due to the distinct biology of childhood cancers. Advances in research have led to improved survival rates and the development of less toxic treatments tailored for young patients. This session will delve into the unique challenges of pediatric cancer, current therapies, and emerging treatments aimed at improving outcomes for children battling cancer.

Tracks:

Track 6-1: Common Childhood Cancers
Track 6-2: Long-Term Effects and Survivorship
Track 6-3: Pediatric Chemotherapy
Track 6-4: Targeted Therapies for Kids
Track 6-5: Innovative Pediatric Clinical Trials

Radiation oncology plays a pivotal role in the treatment of various cancers by using targeted radiation to shrink tumors or kill cancer cells. Advances in technology, such as precision radiation therapy and proton therapy, have significantly improved treatment accuracy and reduced side effects. This session will explore the latest techniques, applications, and innovations in radiation oncology, focusing on how these treatments are evolving to provide more effective and personalized care for cancer patients.

Tracks:

Track 7-1: Types of Radiation Therapy
Track 7-2: Radiation Resistance
Track 7-3: Stereotactic Radiosurgery
Track 7-4: Radiation Resistance
Track 7-5: Future Directions

Breast cancer remains one of the most common cancers globally, but advancements in early detection, treatment, and prevention are improving survival rates. Research continues to uncover new insights into the genetic and molecular mechanisms of breast cancer, leading to more targeted therapies. This session will focus on the latest developments in breast cancer diagnosis, treatment options, and strategies for personalized care, offering hope for more effective and less invasive treatments.

Tracks:

Track 8-1: Genomic Profiling
Track 8-2: Targeted Therapies
Track 8-3: Support and Survivorship
Track 8-4: Immunotherapy in Breast Cancer
Track 8-5: Chemotherapy and Hormone Therapy

Blood cancers, including leukemia, lymphoma, and myeloma, affect the body's blood-forming tissues and immune system. Recent advancements in treatment, such as targeted therapies and immunotherapies, are significantly improving outcomes for patients. This session will explore the latest breakthroughs in blood cancer research, highlighting the progress made in diagnosis, treatment options, and the development of personalized medicine for these complex cancers.

Tracks:

Track 9-1: Types of Blood Cancer
Track 9-2: Stem Cell Transplants
Track 9-3: Targeted Therapies
Track 9-4: Immunotherapy for Blood Cancer
Track 9-5: Long-Term Management

Oral and oropharyngeal cancers are a diverse group of cancers affecting the mouth, throat, and surrounding structures. With an increasing focus on early detection and prevention, significant strides have been made in understanding the risk factors, such as tobacco use and HPV infection. This session will discuss the latest advances in diagnosing, treating, and preventing oral and oropharyngeal cancers, along with the emerging role of immunotherapy and targeted therapies.

Tracks:

Track 10-1: Risk Factors
Track 10-2: Surgical Treatment
Track 10-3: Radiotherapy and Chemotherapy
Track 10-4: Immunotherapy and Targeted Therapy
Track 10-5: Rehabilitation and Quality of Life

Dermatologic oncology is dedicated to the diagnosis and management of skin cancers, which encompass melanoma, basal cell carcinoma, and squamous cell carcinoma. With advancements in early detection and targeted therapies, the prognosis for many skin cancer patients has improved. This session will explore the latest research on skin cancer prevention, innovative treatments, and the role of immunotherapy and genetic testing in personalized care. A comprehensive approach to managing skin cancers, including surgery, radiation, and novel therapies, will also be discussed.

Tracks:

Track 11-1: Types of Skin Cancer
Track 11-2: Genetic Testing
Track 11-3: Surgical and Non-Surgical Treatments
Track 11-4: Immunotherapy in Dermatologic Oncology
Track 11-5: Prevention and Awareness

Pathology plays a critical role in cancer diagnosis and prognosis by providing essential insights into the cellular and molecular characteristics of tumors. Through techniques like biopsy, histopathology, and molecular profiling, pathologists help determine the type, stage, and aggressiveness of cancer, guiding treatment decisions. This session will focus on the advancements in diagnostic pathology, the integration of molecular diagnostics, and how these innovations are shaping personalized cancer care and improving patient outcomes.

Tracks:

Track 12-1: Role of Pathology in Cancer Diagnosis
Track 12-2: Histopathology Techniques
Track 12-3: Molecular Profiling in Cancer
Track 12-4: Cancer Staging and Grading
Track 12-5: Prognostic Biomarkers & Innovations in Pathology

Cancer pathophysiology explores the complex biological processes that lead to the development and progression of cancer. It involves changes at the molecular, genetic, and cellular levels, including mutations, abnormal cell division, and immune system evasion. This session will delve into the underlying mechanisms driving cancer, examining how tumors form, metastasize, and interact with their environment. Understanding these processes is crucial for developing targeted therapies and improving cancer prevention and treatment strategies.

Tracks:

Track 13-1: Genetic Mutations
Track 13-2: Angiogenesis
Track 13-3: Immune Evasion
Track 13-4: Metastasis
Track 13-5: Immune Evasion & Therapeutic Implications

Cancer nanotechnology is an innovative field that applies nanotechnology to detect, diagnose, and treat cancer. By utilizing nanoparticles and nanomaterials, researchers are developing targeted drug delivery systems that can selectively treat cancer cells while minimizing damage to healthy tissue. This session will explore the latest advancements in nanotechnology, including its role in early cancer detection, precision medicine, and the development of novel therapies, offering hope for more effective and less invasive cancer treatments.

Tracks:

Track 14-1: Nanoparticles for Drug Delivery
Track 14-2: Nanomaterials in Cancer Therapy
Track 14-3: Early Detection with Nanotechnology
Track 14-4: Tumor Imaging Techniques
Track 14-5: Challenges and Future Directions

Palliative care in cancer focuses on providing relief from the symptoms and suffering associated with cancer, rather than attempting to cure the disease. It is an essential component of cancer care, aimed at improving the quality of life for patients and their families by managing pain, psychological stress, and other symptoms. This session will cover the importance of palliative care in cancer treatment, addressing both physical and emotional needs, and explore the integration of palliative care in all stages of cancer treatment to ensure comprehensive support for patients.

Tracks:

Track 15-1: Principles of Palliative Care
Track 15-2: Pain Management
Track 15-3: Emotional and Psychological Support
Track 15-4: Integrating Palliative Care
Track 15-5: Importance of Family Involvement

Cancer interventions and techniques encompass a wide range of methods used to diagnose, treat, and manage cancer. These include traditional approaches like surgery, chemotherapy, and radiation, as well as cutting-edge technologies such as targeted therapy and immunotherapy. This session will explore the latest advances in cancer treatment modalities, focusing on how innovative techniques are improving outcomes and offering more personalized treatment options for patients, with an emphasis on minimizing side effects and enhancing recovery.

Tracks:

Track 16-1: Surgical Interventions
Track 16-2: Chemotherapy and Radiation
Track 16-3: Targeted Therapy
Track 16-4: Immunotherapy
Track 16-5: Minimally Invasive Techniques

Gynecologic and prostate cancers are among the most common types affecting individuals worldwide, with gynecologic cancers including ovarian, uterine, and cervical cancers, and prostate cancer being one of the most prevalent cancers in men. Advances in early detection, treatment, and personalized care have significantly improved patient outcomes. This session will delve into the latest research, treatment options, and preventative strategies for both gynecologic and prostate cancers, emphasizing the importance of early diagnosis and multi-disciplinary care for effective management.

Tracks:

Track 17-1: Types of Gynecologic Cancers
Track 17-2: Prostate Cancer  Characteristics
Track 17-3: Symptoms and Diagnosis
Track 17-4: Treatment Options & Emerging Therapies 
Track 17-5: Patient Support and Care

Cancer interventions and techniques involve various methods for diagnosing, treating, and managing cancer. These methods range from conventional approaches such as surgery, chemotherapy, and radiation to advanced technologies like targeted therapy and immunotherapy. This session will examine the most recent developments in cancer treatment options, highlighting how innovative techniques are enhancing patient outcomes and providing more personalized care while aiming to reduce side effects and promote recovery.

Tracks:

Track 18-1: Cancer Incidence and Prevalence
Track 18-2: Survival Rates and Prognosis
Track 18-3: Cancer Epidemiology Methods
Track 18-4: Early Detection and Screening
Track 18-5: Global Cancer Burden

Cancer genomics and epigenetics focus on the genetic and molecular alterations that drive cancer development and progression. Genomic changes, such as mutations and gene amplifications, play a central role in the initiation of cancer, while epigenetic modifications can influence gene expression without altering the DNA sequence. This session will explore the latest discoveries in cancer genomics and epigenetics, highlighting their potential in early detection, targeted therapy, and personalized medicine, which are revolutionizing cancer treatment approaches.

Tracks:

Track 19-1: Genomic Alterations in Cancer
Track 19-2: Epigenetic Modifications
Track 19-3: Next-Generation Sequencing
Track 19-4: Cancer Biomarkers
Track 19-5: Therapeutic Implications

Cancer immunology focuses on understanding how the immune system interacts with cancer cells, and how tumors evade immune surveillance. Immune therapies, including immunotherapy and checkpoint inhibitors, harness the body’s immune system to target and destroy cancer cells. This session will explore the latest breakthroughs in cancer immunology, highlighting how immune system modulation can enhance cancer treatment, reduce tumor growth, and offer new hope for patients, particularly in cancers resistant to traditional therapies.

Tracks:

Track 20-1: Immune System and Cancer
Track 20-2: Immunotherapy Approaches
Track 20-3: Checkpoint Inhibitors
Track 20-4: CAR-T Cell Therapy
Track 20-5: Tumor Microenvironment & Combining Immunotherapies

Cancer pharmacology and drug development focus on the creation of new medications aimed at treating cancer more effectively. This includes understanding the mechanisms of drug action, resistance, and the design of targeted therapies. Recent advances in drug development have led to the emergence of more effective and personalized treatments, offering improved survival rates and reduced side effects for patients. This session will explore the latest advancements in cancer drug development, from preclinical research to clinical trials, and the challenges in bringing these therapies to market.

 Tracks:

Track 21-1: Mechanisms of Drug Action
Track 21-2: Targeted Therapies & Drug Resistance
Track 21-3: Preclinical Research
Track 21-4: Clinical Trials
Track 21-5: Personalized Medicine

Cancer encompasses a wide range of diseases characterized by uncontrolled cell growth and spread to other parts of the body. Different types of cancer arise in various organs and tissues, with each type having unique characteristics, risk factors, and treatment strategies. Understanding the various cancer types is essential for diagnosing and developing effective treatment plans. This session will explore the most common and rare forms of cancer, highlighting their causes, symptoms, and emerging therapeutic approaches.

Tracks:

Track 22-1: Carcinoma
Track 22-2: Sarcomas
Track 22-3: Leukemias
Track 22-4: Lymphomas
Track 22-5: Melanomas & Rare Cancers

Case reports and case series are essential tools in understanding the complexities of cancer and its surgical treatment. They offer in-depth insights into individual patient experiences, treatment outcomes, and novel approaches to managing various cancer types. By documenting unique or rare cases, these reports contribute to the body of knowledge, helping healthcare professionals refine diagnostic techniques, treatment protocols, and surgical strategies. This session will highlight significant case studies in cancer surgery, focusing on the lessons learned from specific patient cases and their impact on clinical practice.